1-alkyl-2-acetyl-sn-glycerol
10-cell
8-fluo-camp binding
95% confidence interval
95% confidence level
abdominal problems
abnormal body composition
abnormal cardiac t2
abnormal hr variability
abnormal liver texture
abnormal scn5a mrna splicing
absorption function
acetylcholinesterase inhibitor pyridostigmine
acid
acquired heart failure
acs procedures
actin cytoskeleton pathways
activated caspase
activated neurohormonal systems
activating myocardial pde2
activators
acute autonomic nervous system modulation
acute care hospital
acute care hospitals
acute decompensated hf
acute hf diagnosis
acute treatment
ad-c
ad-flk
ad-flk rats
adenoviral vector
adjunctive treatment
administratie
admission median
admission nt-probnp
admission to discharge
adult medicine
adults
advanced chronic obstructive pulmonary disease
advanced heart failure
advanced heart failure therapy
adverse event rates
aerobic
aerobic capacity
aerobic exercise
aerobic exercise training
aerobic training
af patients
af type
af-free probability
after contrast agent administration
age
aggressive medical treatment
aggressive protocols
aim
air pollution
akt
albumin concentration
albumin level
albumin levels
alcohol
aldactone evaluation study
aldosterone antagonist eplerenone
aldosterone antagonist therapy
algorithms
allopurinol rats
alphalisa immunoassays
altered regulation
alternatieve treatments
ambient air pollution
ambulatory heart failure trial
ambulatory hf
ambulatory icd patients
ambulatory patients
american
ami admission
ami mortality
ami patient
amyloidotic pattern
an
anabolic imbalance
anemia treatment
ang ii infusion mouse model
angelis salt
angiotensin converting enzyme inhibitors intolerance
angiotensin ii infusion
angiotensin receptor
angiotensin receptor antagonist valsartan
ann arbor veterans affairs
annular size reduction
ans
ans mice
anterior leaflet opening
anthracycline exposure
anthracycline metabolism
anthracycline-containing chemotherapy
anthracycline-induced cardiotoxiciteit
anthracycline-related congestive heart failure
anthracycline-treated breast cancer patients
anti-inflammatory effects
antiarrhythmic medication
antirheumatic drug
antitumor activity
anxiety
aortic blood flow
aortic pressure curve
aortic valve procedures
aortic valve repairs
aortic valve replacement
aortic valve surgery
apical rotation
appendicular lean mass index
arg16
aric hf
aric hf model
arrhythmia events
arrhythmia substrate
arrhythmia-related costs
artificial pulse
as
assay
asymptomatic pediatric fontan
atheromatous coronary disease
atp demand
atrial structure
atropine infusion
attention control
augmented cyclic guanosine monophosphate
autopsy samples
b
b treatment
band
barriers to exercise
basal contractility
basal rotations
base hgb
baseline echocardiography
baseline electrocardiogram
baseline glomerular filtration rate
baseline hrqol
bb dose
bb therapy
bcl-2 mrna expression
bcl-2 proteins
bcl-2/bax
beagle dogs
beat-to-beat qt interval
beat-to-beat qt intervals
behavioural-change
benefit
benefits
bet bromodomain-containing protein 4
bet inhibition
beta-blocker dose
beta-blocker therapy
bhlh transcription factor
binding
bioinformatic analysis
biomarker studies
biomarker-guided clinical
biomarker-guided clinical trial
biomedical reasons
biomedical treatment
black ethnicity
black patients
black race
blacks
blood loss
blood pressure control
blood testing
blood-flow paths
blunted cardiac Î²-ar responsiveness
blunts beta-adrenergic responses
bnp level
body composition
body fat distribution
body mass
body weight
bone morphogenetic protein
borderline
bradycardic response
brd4)
breast cancer patients
breath
breath-holding
breathing control
bridge to recovery
bridging therapy
bromodomain inhibition
bt
budget
burden
c d hf
c gm
c pcs
c-kit+ cell differentiation
c-kit+ cell phenotype
c-kit+ cell yield
c57bl
ca(2+)-pump
ca(2+)-uptake
ca2
calf muscle
california office of statewide healthplanning and development patient discharge
caloric restriction
camp hydrolytic activity
camp production
camp-dependent protein kinase
canadian
canadian special access programme
cancer
cancers
candesartan in heart failure assessment
canine electromechanics
carbohydrates
cardiac autonomic balance
cardiac benign tumors
cardiac biology
cardiac c-kit
cardiac centre
cardiac comorbidities
cardiac diameters
cardiac energy metabolism
cardiac explant
cardiac explant-derived cells
cardiac gene control
cardiac genes
cardiac hypertrophic response
cardiac insulin-resistance
cardiac irs1
cardiac l-type channel activity
cardiac magnetic resonance postcontrast
cardiac magnetic resonance t1 mapping
cardiac mena deletion
cardiac myocyte-specific mena overexpression
cardiac nurse
cardiac nurses
cardiac pathogenesis
cardiac pathology
cardiac pathophysiology
cardiac patients
cardiac performance
cardiac procedures
cardiac risk
cardiac sodium current
cardiac specialty hospital
cardiac surgery
cardiac sympathetic tone
cardiac sympathovagal balance
cardiac symptoms
cardiac tissue
cardiac tissues
cardiac transplant recipients
cardiac transplant survival
cardiac vagal
cardiac vagal tone
cardiologist
cardiology practices
cardiology services
cardiomyocyte-like cells
cardiomyopathic restriction to flow
cardiomyopathy origin
cardioprotective effect
cardiopulmonary exercise
cardiotoxiciteit
cardiovascular complications
cardiovascular conditions
cardiovascular event rate
cardiovascular health
cardiovascular hospitalization
cardiovascular mortaliteit
cardiovascular outcomes
cardiovascular reason
cardiovascular risk factors
cardiovascular surgeons
cardiovascular system
cardioverter
cardioverter-defibrillator deactivation
care management
carotid baroreflex activation therapy
carotid bodies
carotid intima-media
caspase 3 expression
caspase-3 gene expression
catabolism
catalytic
catecholamine infusions
catheter system
caucasian
cav1.3 channels
cava
ccq
ccq summary scores
cd34
cd34+vegfr2
cdp
cell expansion protocols
cells overexpressing
centers for medicare
centrale end-systolic pressure
centrale pattern generator
centrale venous pressure
centrimag right ventricular assist device
centrimag rvad
cerebral blood flow
cf devices
cf lvad
cha2ds2vasc score
chagas
char programme
chart review
chelation choices
chelation regimens
chemotherapy-induced heart failure
chest radiation
chf atrial explants
chf patients
chf patients intubated
chf treatments
chf-developed infarcted animals
chf-dnx
chf-inv
chf-inv group
chf-inv rabbits
children
chinese herbal medicine
chm
choline
cholinephosphotransferase
chromatin remodeling
chromatin-dependent signal transduction
chromatin-mediated signal transduction
chronic advanced heart failure patients
chronic disease
chronic hf-ref
chronic insulin exposure
chronic kidney disease epidemiology collaboration equation
chronic stable guideline-directed medical therapy
circulating
circulating forms
circulating fragments
circulating mediator
circulating nt-probnp
circulating plasma
circulatory arrest
circulatory derangement
circumferential shortening
class i
class i recommendations
class ii
class ii heart failure
class iii
clcnka gg genotype
clcnka polymorphism
clcnka snp
clin
clinic outpatients
clinical composite response
clinical excellence registry
clinical modification codes
clinical trial registries
cmf-dnx
cmf-inv
co correlated
co-morbidity burden
cochrane databases
cochrane effective practice
cognitive function
cognitive impairment
collagen density
colon
combinatied care management
community outpatient settings
competitive
computed tomographic angiography
computing readmissions
concurrent hf
confidence level
congenital abnormalities
congenital accessory pathways
congenital heart lesions
congestive heart failure exacerbation
congestive heart failure phenotypes
congestive heart failure trial
congestive heart failure visits
congestive symptoms
conscious dogs
consenting ambulatory hf patients
contemporary heart failure
content-driven telehealth technology
continuous wave
contrast agent
control group
controlled trial investigating outcomes of exercise training
corporeal membrane oxygenation
cost
cost-efectiveness model
costs
coupling
cox
cox model analysis
cox proportional hazard
cox proportional hazards
cpet guiding exercise rehabilitation
cpg-recommended pharmacological treatment
creatine kinase
creatine kinase activity
cronbach
cross-talk between the heart
crt implantation
crt off
crt on
crt on assignment
crt response
crt-d recipients
crude
crude rr
cultured cardiomyocytes
cumulative administration
cumulative urine volume
currents
curve
cutoff level
cutoff value
cv events
cystatin c level
cytotoxic effect
danish heart failure database
dapc protein levels
dash diet scores
deactivation
debilitating stroke
decongestion end point
decoy vegf receptor
defibrillator-crt
defibrillator-only therapy
delayed rhythm control
dementia
depressed left ventricular
depression
depressive symptoms
derivation cohort
detergent
development and evaluation
device
device consideration
device implantation
device therapies
devices
diabetes status
diabetic zsf1 rats
diagnose
diagnosti
diagnosti performance
diagnosti procedures
diagnosti test
dialysis patients
dialysis-dependent patients
diameter stenosis
diastolic indices
diastolic mitral flow velocity
diastolic mitral leaflet
diastolic properties
diet
diet adherence
diet score
diet scores
dietary interventions
diffuse myocardial changes
dilated poorly contracting ventricles
diminished cyclic adenosine monophosphate
direct renin inhibitors
discharge patients
discharged alive
discharged patients
discrimination
discrimination improvement
disease management
disease management programs
disease recapitulates
disturbed intestinal barrier
dithiothreitol
diuretic efficacy
diuretic refractory
diuretic resistant volume overload
diuretic response
diuretic therapy
diuretic use
dm
doppler imaging
double mutant
doxorubicin cardiotoxiciteit
doxorubicin efflux transporter abcc2
doxorubicin treatment
doxorubicin-induced cardiotoxiciteit
doxorubicin-induced heart failure
driveline infection
driveline injury
drs deciles
drs-stratified hazard ratios
dual ras
dyn
dynamic
dynamic resistance training
e gfr
e-septal
e/e'lateral
e/e'mean
e/elateral
e/emean
e/eseptal
early diastolic mitral flow velocity
early medical management
early rhythm control therapy
early transmitral blood flow velocity
early transmitral flow
early-onset hf
ec coupling
ecb
eccentric
ecg parameters
echo-doppler studies
echocardiographic assessment
echocardiographic examination
echocardiographic measurements
echocardiographic measures
echocardiographic score
echocardiographic substudy
echocardiographic systolic parameters
ecmo group
ecmo+vad
ecmo+vad group
economic analysis
economic climate
economic evaluations
economic impact
economic models
economische
ect
ed patients
ed physicians
ed visit
ed visits
eeo-cfus
efficacy in vivo
efficiency
egfr group ii
egfr group iii
egfr group iv
ejection
elastance
elastic n2 bus segment
elderly
elderly patients hospitalized
electrical activation sequence
electrocardiographic device
electromechanical behavior
electronic databases
elektrial activation
elevated left atrial pressure
embryonic gene programs
emotional status
emotional stress
emphasis-hf study
encoding truncated
end-diastolic dimension
end-diastolic dimension index
end-stage congestive heart failure
end-tidal co2
endothelial repair
endothelial-protective effects
energie expenditure
energy deficit
energy transfer-based assays
enos-ser
enos-thr
enrollment
epigenetic readers
eplerenone post myocardial infarction
erasers
erd
erk1/2 molecular scaffolds
erk1/2 signalling
erythropoiesis-stimulating agent therapy
et
eth
ethically
etidronate-
etiologic causes
eu-cfu
euras
europa
europese society of cardiology guidelines
exchange malfunctioning heartmate ii lvads
exercise
exercise adherence
exercise group
exercise performance
exercise programmes
exercise protocol
exercise time
exercise training
exercise training response
exercise training therapy
exertion
expenditure
expenditures
explant-derived progenitor cells
extracorporeal membrane oxygenation membrane support
failing heart
failing hearts
familiar physician
fat
fat loss
fat mass index
fat-free mass index
fatigue
fee-for-service
feeding
female
fes group
fetal gene program
fiber
financiÃ«le burden
fish
fit
fit men
fixed-rate atrial pacing
flow-mediated dilatation diameter
fluorescence resonance
flutter
follow up body weight
follow-up echocardiograms
follow-up exercise capacity
follow-up medication
follow-up tests
follow-up visits
fontan adults
force
forkhead box
fpassive-sarcomere length
fractal scaling exponent
framingham heart study criteria
free wall
free-breathing pulse sequence
full medicare coverage
function
function in vitro
functional abnormalities
functional class iii hf
functional class nyha ii-iii
functional deficits
furosemide dose
futility
g-protein-coupled receptor kinase-2
gbf
gdm
gem
gene expression profiling
gene programs
genetic susceptibility
geometry
germline dna
get with the guideline- heart failure registry
get with the guidelines- heart failure
gln27
global longitudinal strain
global proteomics
glomerular filtration
glucose transporter
gly16
glycosylated
gm-treated nyha functional class iii hf
grading of recommendations assessment
gross income
gross national income per capita
growth factor-Î²
gtpase rac1
guideline recommendations
h
haard ratio
habc battery score
habc battery scores
haemodynamic outcomes
haemodynamic stress
hand
hand grip strength
handling
hb
hbf
hdl function
hdl particles
hdl-bound malondialdehyde
hdl-mediated protective effects
hdl-mediated vascular effects
health abc
health care expenditures
health insurance
health per capita
health service provision
health status
health system
health systems
healthcare utilization
healthy cardiomyocytes
heart failure adherence
heart failure admission
heart failure admissions
heart failure clinic
heart failure discharges
heart failure disease management
heart failure efficacy
heart failure hospitalization
heart failure hospitalizations
heart failure mortality
heart failure nurses
heart failure patients
heart failure treatment
heart failure-related hospitalization
heart failure-related mortality
heart failure-related qol
heart muscle cells
heart pathology
heart rate response
heart rate variation
heart t2
heart team
heart transplant recipients
heartmate ii devices
heartmate ii exchange
heartmate ii implantation
heartmate ii insertion
heartmate ii lvad
heartware intl
heartware patients
helix-loop-helix
hemodynamic alterations
hemodynamic disorder
hemodynamic perturbations
hemodynamic status
hemodynamically unstable
hemoglobin levels
hemoglobin threshold
hemolysis events
hepatic function
hf admissions
hf clinic
hf cohort
hf cpgs
hf epidemiology
hf evolution
hf hospital admissions
hf hospitalisations
hf hospitalization
hf met preserved ejection fraction
hf met reduced ejection fraction
hf model
hf mortality
hf mortality risk
hf pathogenesis
hf pathophysiology
hf patient plasma
hf patients
hf progression
hf rats
hf registry
hf resources
hf risk factors
hf tissues
hf units
hf volume management
hf-action cohort
hf-induced remodeling
hf-related cachexia
hfpsi model
hfref therapy
hfvt
hg
hg Î² coefficient
hgb level
hhf
high-fat diet
high-frequenncy
high-volume ed
high-volume eds
high-volume physicians
histological analysis
hnorm
hnorm group
hoge-density lipoprotein
home telemonitoring
hoog-cost medicare
hospital clustering
hospital days
hospital discharge
hospital mortality
hospital rankings
hospital rates
hospitalized heart failure
hospitalized hf
hospitalized patients
hr dynamics
hr variabiliteit
hretn
hum-retn
hum-retn mice
human
human heart failure
human hf
human myocardial tissue
human rad q66p
human resistin
humanized male mice
humans
humoral stimuli
hvad devices
hybrid system
hypertension diet
hypertrophied heart
i
i-meta-iodobenzylguanidine
i-mibg
i2
iccs
icd-hf
icd-hf patients
icu admission
idiopathic dilated cardiomyopathy cohort
if inhibitor ivabradine trial
ii-mibg cardiac washout
il 6
immunoreactive nt-probnp
implantable cardioverter
implantable cardioverter defibrillator-crt
implantable cardioverter-defibrillator deactivation
implantable cardioverter-defibrillator device
implantable cardioverter-defibrillator shocks
implantable cardioverter-defibrillator therapy
implanted monitoring devices
in vivo inhibition
in vivo rv
in-patient follow-up
in-trial resource utilization
inactive cxl-1051
inappropriate shock therapy
incident cardiovascular events
incident hf
index
index admission
index ami
index beat method
index ed visit
index hf
induced pluripotent stem cell-derived cardiomyocytes
inducible myocardial ischemia
industrial areas
inesthetized dogs
infarcted hearts
infarcted rats
infarction-related refractory right heart failure
inflammation-stimulated resistin
inflammatory abdominal problems
inflammatory biomarkers
inflammatory markers
inflammatory state
inflammatory stimul
ingenuity
inhibitor jq1
inhibitors
inhibitory actions
inhospital mortaliteit
inhospital mortality
inhospital outcomes
inoperable chronic thromboembolic pulmonary hypertension
inotrope-dependent
inpatient admissions
inpatient medical conditions
inpatient records
insulin action
insulin products
insulin receptor substrates
insulin-signaling components
insulin-stimulated rates
insurance status
intact hearts
interleukin receptor family member
intermediate frail
intermediate frailty
intermediate metabolism
intermuscular fat ratio
internal reliability
interne consistency
interventions
interventricular septum biopsies
intestinal morphology
intl
intracellular antiadrenergic therapeutic strategy
intravenous atropine
intravenous inotropes
intravenous iron
intravenous metoprolol
intrinsic left ventricular dysfunction
intubation rates
invasive hemodynamic
ip
iron
iron deficiency
iron-deficient adult patients
irs2 double-knockout
irs2 gene double-knockout
irs2 proteins
ischemic etiology
ischemic hf pathogenesis
ischemic right heart failure
ischemic samples
isolated cardiomyocytes
isolated heart rate
isolated heart transplant
isolated heartmate ii
isolated heartmate ii lvad
isolated hr reduction
isolated lvad
isolated myoctyes
isolated pump replacement
isoprenaline infusion
ivabradine group
ivabradine unloads
japanese heart failure patients
jehovahs witness
joanna briggs institute voor reviews and dissemination
joint effect
kaiser permanente northern california
kansas city cardiomyopathy questionnaire summary
kcal
kccq overall summary
kccq scales
kcl-ki treatment
keletal muscle abnormalities
kg
kidney index score
kidney injury
kir
knockdown
kosten
kosten-efectiveness model
kosten-effectiveness
kv4.3 channel mrnas
kv4.3 mrna levels
l-dko mice
l-type ca2
l-type channel inhibition
l-type channel isoforms
label-free shotgun
laboratory report
lancet
lateral wall
lb
lbb
lc-ms
leaflet motion
leaflet repair
leaflet resection
lean
lean body mass ratio
lean zsf
left
left heart
left main
left ventricular assist device implantation
left ventricular biopsies
left ventricular ejection
left ventricular function assessment
left ventricular longitudinal systolic strain
left ventricular mechanics
left ventricular midpapillary level
left ventricular tissue
left-hand grip
left-to-right interatrial shunt
left-to-right interatrial shunting
leg strength
legal majority
length-force
length-force relationship
leu3-gly4
lf
liberal transfusion protocols
life-sustaining treatment
lim27 haplotype
line
lipid-lowering therapy
lipoprotein-associated phospholipase
littermate
littermates
liver-specific irs1
log2
logistic regression models
lokomatÂ® system
long-term mortality
longitudinal strain
low left ventricular ejection fraction
low left ventricular ejection fractions
low testosterone status
low-dose dopamine
low-frequenncy
low-sodium dash diet
low-volume ed
low-volume ed cases
low-volume eds
low-volume hospitals
low-volume physicians
lower body mass index
lower limbs
lp-pla2]
lung congestion
lung weight
lv end systolic volume index
lv posterior wall thickness
lv structure
lv systolic dysfunction
lvad implantation
lvad insertion
lvad surgery
lying
lz696
m2
madit-crt trial
magnetically levitated centrifugal-flow chronic lvas
magnetically levitated left ventricular assist system
magnetically levitated rotor
main outcome
male sex
males
malignancies
malignant disease
management
markers voor coagulability
mass
md
mean ejection fraction
measuring np levels
mechanical
mechanical dyssynchrony
mechanical support devices
mechanism
mechanism of action
mechanism of cardioprotection
mechanisms of disease
mechanistic insight
median follow-up
medicaid 30-day readmission
medicaid services
medical hospitalization
medical management
medical outcomes study short-form quality of life domains
medical records
medical staff
medical support
medical therapies
medical treatment guidelines
medically managed diseases
medicare hospital claims
medicare inpatient
medication regimen
mediterranean
mediterranean and dietary approaches to stop hypertension
mediterranean diet score
mediterranean diet scores
medium
medium-volume eds
men
mesenchymal transition markers
metabolic abnormalities
metabolic enzymes
metabolic risk factors
metoprolol treatment
metric
mhf
mi diagnosed
mice
mid lad
midwestern state
migration
minnesota living with heart failure
mir-25 expression
mistargeting
mitochondrial complex
mitochondrial damage
mitochondrial oxidative stress
mitochondrial ultrastructural
mitochondrial-targeted antioxidant
mitochondrial-targeted peptide drugs
mitochondrial-targeted peptide ss31
mitral e/e wave ratio
mitral filling flow volume
mix
ml
mlhf
molecular biomarkers
molecular level
molecular mechanism
morbiditeit
morpholino-based knockdown
mortaliteit
mortality rates
mouse
mouse heart
mouse heart failure
mouse hearts
mouse hf model
mouse myocardium
mouse rad q65p
mouse tac model
mouse ventricular myocytes
mri-based models
mrna level
mrna levels
msms
mt
multicenter automatic defibrillator implantation
multiparametric echocardiographic score
murine equivalent
murine myocardium
murine resistin
muscle function
muscle strength
muscle strip stiffness
muscle strips
muscle wasting
muscle-wasting syndrome
muscular strength
mutant mice
mwt
myocardial delayed enhancement imaging
myocardial extracellular matrix accumulation
myocardial glycolysis
myocardial infarction-both
myocardial loss
myocardial pde2 expression
myocardial phosphodiesterase-2
myocardial titin hypophosphorylation
myocardium displays
myocyte diameter
myocyte hypertrophy antecedent to heart failure
myofiber
myofibrillar ca(2+)-stimulated atpase activity
myosin binding
n-terminal fragment
na+ channel mrna splice
na+ current
nad(ph-oxidase subunit rac2
nanomolar doses
national cardiovascular disease registry
natriuretic peptide system
nct
negative coronary angiography
negative cross talk
neonatal rat ventricular cardiomyocytes
neprilysin blocks
nesiritide strategy
net economic savings
net reclassification
neurohormonal abnormalities
neurohormonal activation
neurohormonally induced heart disease
neutral endopeptidase inhibitors
new york heart association class ii to iv hf
new york heart association class iii heart failure
new zealand white rabbits
nfat signalling
nights spent in hospital
ninth revision
nitric oxide donors
nmol
no production
non-aas
non-biological disease
non-diabetic patients
non-diastolic abnormalities
non-dnx
non-fatal stroke
non-frail
non-ischemic
non-lbbb
non-linear hr variability
nonadherence
noncardiac
noncardiologist physicians
noncardiovascular diagnoses
noncardiovascular drugs
noncoding rnas
nondiabetes risk factors
nondiabetic patients
nonfunctional channels
nonglycosylated
nonpace
nonselective
nonsurvivors
nontrastuzumab
nontraumatic death
nontreatment
nordic walking
norepinephrine-induced hypertrophic responses
normal geometry
northwest united states
np assessment
np measurement
nt-probnp assay
nt-probnp cutoff point
nt-probnp testing
nurse assessment
nurse leaders
nursing care
nursing management
nursing-sensitive outcome change scores
nutrition
nutritional strategies
nuts
nyha functional assessment
nyha functional class ranking
o-1 signaling
o2 consumption rate
obese body mass index
obese men
obese older patients
obese zsf
off-pump
office hours
older adults
older adults hospitalized
older patients
open chest model
open stent
open surgery
open-label crossover study
oral glucocorticoid dosage
oral glucocorticoids
organisation of care taxonomy
oscillatory ventilation
outpatient models
overexpressing hand2
overweight
overweight body mass index
oxidative stress markers
oxygen consumption
oxygen flow
oxygen pulse
oxygen uptake
p. arg83gly
p38alpha mapk
p38Î± mitogen-activated protein kinase
p70s6k-ser
pace
pace non-dnx
paced myocardium
paediatric cardiac transplants
paediatric heart failure
paf biosynthetic enzymes
paradigm shift
parasympathetic function
parasympatische activity
passive
patent
pathological cardiac gene expression programme
pathological gene expression
pathological gene induction
pathological heart disease
pathological stress
pathophysiologic mechanism
pathophysiologic mechanisms
pathway analysis
patient enrollment
patient management interventions
patient safety
patients hospitalized
patients met heart failure
patients with chronic heart failure
pbf-cpt
pcp
pde superfamily
pde2 expression
pde2 overexpression
pde2-mediated effects
pdrelated complications
pediatric heart failure
pediatric mechanical cardiac
pediatrics
penalties
percutaneous coronary revascularization
percutaneous revascularization
perk activation
perk inhibition
permanent periodic breathing
permeability
pevk segment
pf cohort
pharmaceutically assisted
pharmacologic management
pharmacologic studies
pharmacologic therapies
pharmacologic treatment
pharmacological armamentarium
pharmacological treatment
phenylephrine-induced genes
physical activity
physical exhaustion
physician adherence
physician continuity
physician follow-up
physician volume
physio ring
physiological proteolysis
pigs
pka subunits
pkc-Î²ii-ser
placebo group
plasma collected
plasma samples
plasmab-type natriuretic peptide
plasticiteit
pleasanton calif
pluripotency marker nanog
poc measurement
poc systems
poc technology
poc testing
point-of-care systems
policy
polytetrafluoroethylene tube
porcine model
positron emission tomography imaging
post- lvad ai
post-acute care transfer
post-acute care transfer policy
post-dash
post-hct chf
post-pd initiation
post-tac cardiac functional deterioration
post-transplant morbiditeit
post-transplant mortality
posteriorly displaced papillary muscles
postmarketing
postmenopausal women
postnatal mammalian myocardium
postoperative echocardiography
postoperative mortality
postoperative survival
practice innovation
pre-crt lv
pre-pd
precipitating factor
prediction rule
preoperative albumin
preserved
preserved cardiac index
pressure
pressure gradient
pressure-overload-induced hypertrophy
pressure-volume conductance
prior stroke score
pro6- gly7
pro75- arg
proangiogenic effects
process redesign contextual framework
prognostic power
programmed cell death
progressive disease
propensity
prostate
protective effects
protein content
protein levels
protein-c phosphorylation
proximal circumflex artery
proximal lad
proximal lcx
proximal left anterior descending
proximal left anterior descending artery
psoriasis patients
pss
psychometric testing
psychosocial factors
public health
public reporting
pulmonary artery snared
pulse-wave velocity
pump exchanges
pump failure
pump malfunctions
pump replacement
pure epicatechin
pure hno donor
q65p substitution
qrs width
qt
quadriceps force
quality of life score
quality-of-life score
questionnaire
r-like er kinase
r-r interval oscillations
r. cluster analysis
rabbits
race
rad q66p
radial artery tonometry
radioenzymatic-
raf-mek1/2-erk1/2
raised blood glucose levels
raloxifene-treated
ras-
ras-blocker uptitration
rat
rat metabolic risk
rate-control strategies
rate-control treatment
rats
readmission metric
readmission metrics
readmission rates
readmission reduction program
receiver operating characteristic curve
recipients
reciprocal downregulation
reciprocal regulation
reclassification
reclassified
recovery
recreational athletes
refill compliance
refractory
regulatory
regulatory subunit
relaxation
religious beliefs
remove heart iron
renal atherosclerotic lesions
renastur cohort
renin- angiotensin-aldosterone
repeat ed
reperfusion therapy
repolarization lability
resistance
resistin levels
respiratory
response
resting
resynchronization reverses remodeling in systolic left v entricular dysfunction
resynchronization-defibrillation
retention trial
retn gene
reverse remodeling parameters
reversible myocardial ischemia
rhythm
rhythm- and rate-control
right atrial area
right atrial mass removal
right atrium mass
right grip strength
right ventricle overload
right ventricular contractile
right ventricular pump
risk
riÎ± proteins
rna polymerase ii
robot-assisted gait therapy
robot-assisted training
ronbach
rose acute heart failure
rotterdam
rr intervals
rtq- pcr
rv failure management
rv function evaluation
s'lateral
s'septal
s1pr
s1pr1 cardiac gene therapy
safety monitoring board
sandwich alphalisa
sarcopenic range
schfi
sci
science
scientific literature
scn5a electric remodeling
scn5a transcript
scn5a variants
sd testosterone
sdqt-to-sdrr ratio
seattle heart failure
self-care confidence scale
self-care maintenance scale
self-care management scale
self-care of heart failure index
self-management counseling
sensitiviteit
septal defects
septal wall
sequential phosphorylation
ser23/24 troponin i phosphorylation
ser83 mutant
ser83 phosphorylation
ser96)
serum creatinine level
serum factors
serum levels
serum potassium level
serum resistin
serum resistin levels
severe cad
sex
sham
sham explants
sham group
sham levels
sham-dnx
sham-inv
sham-operated
sham-operated animals
shams
sheet orientation
shotgun
shunt implantation
shunt implants
signal transduction cascade
signalling cascades
significant regression analysis
significant-volume eds
skeletal muscle mass
skeletal muscle sarcomere structure
skinfold thickness
skm biopsies
skm mitochondrial structure
slowed conduction
smad
small-molecule inhibitors
smoked
smoking
smoking cessation
snared
snp rs10927887
social mandate
social support
socioeconomic status
sodium levels
sodium restriction
sodium-restricted dash diet
sodium-restricted dietary
soluble
soluble guanylate cyclase
soluble st2
southeastern minnesota residents
sp2
sphingosine-1-phosphate receptor
spironolactone dose
sprague- dawley rats
sr ca(2+)-pump function
srd
srd brachial
sst2 concentrations
sst2 measurement
sst2 status
sst2/high-dose bb
sst2/low-dose bb
st2 level
stam-innervated
stand-alone diagnostic devices
standard cardiac rehabilitation
standard heart failure medicines
standing blood pressure
ste analysis
stem cell source
stenotic
stent occlusion
sterf
sternal sparing approach
stiffness
strain rate
stress conditions
stretch rate
stroke prevention trial
structural heart disease
structurally normal hearts
sts hh
sts hm
subcellular alterations
subclinical atherosclerosis
subunit expression
sudden cardiac death
sudden cardiac deaths
sudden death
surgical conditions
surgical patients
surgical revascularization
surgical ring implantation
survival study
survival study in heart failure
sustainability
svr index
swedish national inpatient registry
swedish web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies registry
swine
swine model
sympathetic control
symptom domains
systolic heart failure treatment
systolic human heart failure
systolic indices
t1-mapping techniek
tac surgery
tac-
tac-induced proteomic alterations
tachycardia-induced heart failure
tachycardic response
tapse-to-pasp ratio
taxonomy
techniek
telehealth system
telephone support
termini
tertiary referral centre
testosterone group
testosterone status
texas cancer registry-medicare databases
tgf-Î² inhibition
tgtetmena
thalassaemia
therapeutic targets
therapy refractory cardiogenic shock
thickness
thigh muscle
time domain
time to death
tissue
tissuefaxs technology
titin isoforms
titin modification
tm interventions
to death
tobacco
tobacco use
tonometric indices
tools for economic analysis of patient management interventions in heart failure
total adiponectin
total cholesterol
toxiciteit
trans
transcription
transcription factor dhand
transcription factor gata4
transcription factor networks
transcriptional analysis
transforming growth factor
transfusion thresholds
transgenic mice
transmitral e-wave
transplant pool
transplant-ineligible patients
transplantation eligibility status
trastuzumab-related cardiotoxiciteit
trastuzumab-related chf
trastuzumab-treated patients
trastuzumb-related chf
treadmill exercise testing
treadmill testing
treating advanced hf
treatment
treatment group
treatments
trial investigating outcomes in exercise training
trial investigating outcomes of exercise training
trpm7 channel mrna
truncated na+ channels
tta
tttetmena
tunel assay
turbulence
twist
two-vessel disease
type ii regulatory
u.s. food and drug administration
um cohort
um/va
um/va/ va-rt cohorts
unclear etiology
uncontrolled hypertension
unfamiliar physician
unfit
unfit men
unilateral
unit costs
university of michigan hf clinic
unloading
unplanned readmission
untreated acf
upr effectors
urgent cardiac transplant
urgent readmission
usual care
uv
va cohort
va patients
va-rt
va-rt cohort
vad group
vad groups
vagal
vasodilator effects
vasopressin receptor antagonist therapy
vco2 slope
vd
vegetables
vegfr2
vehicle
velocity time integral
ventricular action
ventricular assist device support
ventricular contractile reserve
ventricular ejection
ventricular power index
ventricular structure
ventricular systolic
ventricular systolic hf tissue samples
ventricular tachycardia storm
ventricular wall stress
ventricularly paced
virtual cohorts
viscoelastic
vivo phosphorylation sites
voltage-gated cardiac
voordelen
waist circumference
walk test
walking
weak grip strength
weekly trastuzumab administration
weight
weight loss
westar-kyoto
western australian linked administrative health
western blot analysis
western society
white
whites
whole grain intake
wilcoxon
wild type
willebrand factor
wistar rats
women
womens health initiative
working hearts
world health organization criteria
wrf
writer
wt
wt riÎ±
xo-mediated ros effects
yorkshire swine
zebrafish
zsf1 group
zsf1 groups
zsf1 rats
zung
Î±
Î²-adrenergic receptor activation
Î²-ar drive
Î²-ar stimulation
Î²-blocker dose
Î²-blocker metoprolol
Î²-blocker uptitration
Î²-blocker uptitrations
Î²-blocker-induced enhancement
Î²-blockers therapy
Î²1ar overstimulation
